Search

everythinglearnresearchcommunity

for

Search:↓

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Blocking the Wnt pathway could lead to new treatments for cancer and tissue repair but requires careful development to avoid side effects.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

New treatments for severe hair loss often fail, but some patients see hair regrowth with specific therapies, and treatment should be tailored to the individual's situation.

A disease causing skin issues in young adult German short-haired pointers is hereditary, with most affected dogs not responding to treatment.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

People with alopecia areata often have lower vitamin D levels, which are linked to more severe and longer-lasting hair loss, but vitamin D receptor levels in the skin don't show the same pattern and don't predict treatment success.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Many women with hard-to-treat acne also have PCOS.

Hormone imbalances can cause skin diseases, and understanding these links is important for diagnosis and treatment.

A woman with scalp lymphoma and hair loss improved with radiotherapy, highlighting the need for biopsies in similar cases.

A five-month-old boy with Omenn syndrome successfully recovered after a stem cell transplant with reduced intensity conditioning.

The document concludes that various childhood hair and nail disorders exist, some may improve on their own, and advances in genetics and immunology could enhance treatment and counseling.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.

BAFF-targeted therapies can reduce autoimmune disease activity, but more research is needed for precise treatments.

The conference highlighted new dermatological treatments and emphasized early intervention and addressing conditions lacking evidence-based treatments.

Disrupted cysteine metabolism may cause hair breakage in Alopecia Areata, suggesting potential treatments like N-acetylcysteine.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

Early diagnosis and aggressive treatment are crucial for Cicatricial Alopecia, and treatment effectiveness varies among patients.

People with alopecia areata have higher levels of osteopontin, which might be important in the disease's development, but this doesn't relate to how severe the disease is.

Birth control pills and anti-androgen medications help manage hair growth, acne, and hair loss in women with PCOS.

Upadacitinib improved multiple immune-related conditions in one patient.

Stem cell activity influences autoimmune disease outcomes by affecting immune responses and tissue regeneration.

SQSTM1 gene issues may increase the risk of alopecia areata.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Microneedling may improve melasma treatment by boosting topical therapy effectiveness.

A specific genetic trait in tumor cells is linked to longer survival without disease in certain lymphoma patients.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.